Advertisement

help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH

First Published Online October 9, 2009
The Oncologist, doi: 10.1634/theoncologist.2009-0022
© 2009 AlphaMed Press
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
theoncologist.2009-0022v1
14/10/963    most recent
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Google Scholar
Right arrow Articles by Damjanov, N.
Right arrow Articles by Haller, D. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damjanov, N.
Right arrow Articles by Haller, D. G.

Gastrointestinal Cancer

Resection of the Primary Colorectal Cancer Is Not Necessary in Nonobstructed Patients with Metastatic Disease

Nevena Damjanov, Jared Weiss, Daniel G. Haller

University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, USA

Key Words. Colorectal neoplasms • Chemotherapy • Colectomy • Review literature

Correspondence: Correspondence: Nevena Damjanov, M.D., University of Pennsylvania, Abramson Cancer Center at Penn Presbyterian Medical Center, 51 North 39th Street, Philadelphia, PA 19104, USA. Telephone: 215-662-9801; Fax: 215-243-3249; e-mail: nevena.damjanov{at}uphs.upenn.edu

Received February 9, 2009; accepted for publication September 10, 2009.

Nevena Damjanov: Honoraria: Amgen, Sanofi-Aventis, Genentech, Bristol-Myers Squibb; Jared Weiss: None; Daniel G. Haller: None.

Asymptomatic patients with metastatic colorectal cancer do not routinely need to undergo resection of the primary tumor. Although several retrospective analyses suggest that patients who undergo resection of the primary tumor live longer, most of these reviewed data prior to the advent of modern polychemotherapy and are subject to considerable bias, as patients who were considered able to undergo surgery likely had better overall prognoses than those who were not. In addition to significant prolongation of overall survival, current combinations of systemic chemotherapeutic agents and targeted agents have allowed improved local and distant tumor control, decreasing the likelihood of local tumor-related complications requiring colon resection.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH RSS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2009 by AlphaMed Press.
Advertisement